Clinical predictors of early second event in patients with clinically isolated syndrome

[1]  E. Waubant,et al.  Predictors of the location of multiple sclerosis relapse , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.

[2]  J. De Keyser,et al.  Predictive value of clinical characteristics for ‘benign’ multiple sclerosis , 2007, European journal of neurology.

[3]  E. Waubant,et al.  Are initial demyelinating event recovery and time to second event under differential control? , 2006, Neurology.

[4]  L. Kappos,et al.  Relapses and subsequent worsening of disability in relapsing-remitting multiple sclerosis , 2006, Neurology.

[5]  R. Marrie,et al.  Does multiple sclerosis–associated disability differ between races? , 2006, Neurology.

[6]  F. Barkhof,et al.  Most patients with multiple sclerosis or a clinically isolated demyelinating syndrome should be treated at the time of diagnosis. , 2006, Archives of neurology.

[7]  M. Trojano,et al.  Age-related gadolinium-enhancement of MRI brain lesions in multiple sclerosis , 2005, Journal of the Neurological Sciences.

[8]  L. Kappos,et al.  Predictors of relapse rate in MS clinical trials , 2005, Neurology.

[9]  S. Reingold,et al.  Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria” , 2005, Annals of neurology.

[10]  D. Shabas,et al.  Multiple sclerosis management for low-income minorities , 2005, Multiple sclerosis.

[11]  J L Haines,et al.  Clinical characteristics of African Americans vs Caucasian Americans with multiple sclerosis , 2004, Neurology.

[12]  S. Weigand,et al.  Change in MS-related disability in a population-based cohort , 2004, Neurology.

[13]  Susan K. Johnson,et al.  Multiple Sclerosis: Severity and Progression Rate in African Americans Compared with Whites , 2003, American journal of physical medicine & rehabilitation.

[14]  C. Granger,et al.  Multiple sclerosis characteristics in A frican A merican patients in the New York State Multiple Sclerosis C onsortium , 2003, Multiple sclerosis.

[15]  P. Adeleine,et al.  Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process. , 2003, Brain : a journal of neurology.

[16]  C. Poser,et al.  Diagnostic criteria for multiple sclerosis , 2001, Clinical Neurology and Neurosurgery.

[17]  Massimo Filippi,et al.  European/Canadian multicenter, double‐blind, randomized, placebo‐controlled study of the effects of glatiramer acetate on magnetic resonance imaging–measured disease activity and burden in patients with relapsing multiple sclerosis , 2001, Annals of neurology.

[18]  M. Filippi,et al.  Enhancement frequency decreases with increasing age in relapsing-remitting multiple sclerosis , 2001, Neurology.

[19]  A. Achiron,et al.  Multiple sclerosis-from probable to definite diagnosis: a 7-year prospective study. , 2000, Archives of neurology.

[20]  G. Comi,et al.  Prognostic value of MR and magnetization transfer imaging findings in patients with clinically isolated syndromes suggestive of multiple sclerosis at presentation. , 2000, AJNR. American journal of neuroradiology.

[21]  Gianfranco Siracusa,et al.  A prospective study on the natural history of multiple sclerosis: clues to the conduct and interpretation of clinical trials , 1999, Journal of the Neurological Sciences.

[22]  I. Moseley,et al.  Multisequence MRI in clinically isolated syndromes and the early development of MS , 1999, Neurology.

[23]  J. Baskerville,et al.  The natural history of multiple sclerosis: a geographically based study. 7. Progressive-relapsing and relapsing-progressive multiple sclerosis: a re-evaluation. , 1999, Brain : a journal of neurology.

[24]  E. Waubant,et al.  A pilot study of MRI activity before and during interferon beta-1a therapy , 1999, Neurology.

[25]  J. Baskerville,et al.  The natural history of multiple sclerosis: a geographically based study. 5. The clinical features and natural history of primary progressive multiple sclerosis. , 1999, Brain : a journal of neurology.

[26]  A. Thompson,et al.  The prognostic value of brain MRI in clinically isolated syndromes of the CNS. A 10-year follow-up. , 1998, Brain : a journal of neurology.

[27]  D. Miller,et al.  The significance of brain magnetic resonance imaging abnormalities at presentation with clinically isolated syndromes suggestive of multiple sclerosis. A 5-year follow-up study. , 1993, Brain : a journal of neurology.

[28]  B Bass,et al.  The natural history of multiple sclerosis: a geographically based study. 2. Predictive value of the early clinical course. , 1989, Brain : a journal of neurology.

[29]  J. Kurtzke.  Rating neurologic impairment in multiple sclerosis , 1983, Neurology.

[30]  B. Dr. C. Hirst MB,et al.  Contribution of relapses to disability in multiple sclerosis , 2008, Journal of Neurology.